p67 and eIF-2 kinases in regulation of protein synthesis using several animal cell lysates and an animal cell line (KRC-7) in culture under various growth conditions. The results are as follows. (s) Both p67 and eIF-2 kinase(s) are present in active forms in all animal cells under normal growth conditions and p67 protects the eIF-2 a subunit from eIF-2 kinase-catalyzed phosphorylation, thus promoting protein synthesis in the presence of active eIF-2 kinases. (u) In heme-deficient reticulocyte lysates and in serum-starved KRC-7 cells in culture, p67 is deglycosylated and subsequently degraded. This leads to eIF-2 kinase-catalyzed eIF-2 a-subunit phosphorylation and thus to protein synthesis inhibition. (iii) Addition of a mitogen (namely, phorbol 12-myristate 13-acetate) to serum-starved KRC-7 cells in culture induces an increase of p67 and thus increases protein synthesis. These results suggest the following conclusions. (a) Protein synthesis inhibition in a heme-deficient reticulocyte lysate is not due to the activation of an eIF-2 kinase (heme-regulated inhibitor), as is generally believed, but is due to degradation of p67. The heme-regulated inhibitor is present in an active form and possibly in equal amounts in both heme-deficient and heme-supplemented reticulocyte lysates but cannot phosphorylate eIF-2 a subunit because of the presence of p '7. (ii) p67 is essential for protein synthesis as it protects the eIF-2 a subunit from eIF-2 kinase-catalyzed phosphorylation and promotes protein synthesis in the presence of one or more active eIF-2 kinases present in all animal cells. (iii) p67 is both degradable and inducible. Only the p67 level correlates directly with the protein synthesis activity of the cell, indicating that p67 is a critical factor in protein synthesis regulation in animal cells.
A widely used protein synthesis regulatory mechanism in animal cells involves phosphorylation of the a subunit of a key peptide chain initiation factor, eukaryotic initiation factor 2 (eIF-2), by one or more eIF-2 kinases, which inhibits protein synthesis. In several cases studied, these inhibitors appear to remain in an inactive form and are activated under certain physiological conditions. Numerous reports indicate that in reticulocyte lysates one inhibitor, heme-regulated inhibitor (HRI), is activated in the absence of hemin and another inhibitor, double-stranded-RNA-activated inhibitor (dsI), is activated in the presence of double-stranded RNA (for reviews, see refs. 1 and 2). In both cases the activated inhibitor specifically phosphorylates the eIF-2 a subunit and thus inactivates eIF-2 activity and inhibits protein synthesis.
As noted earlier, this regulatory mechanism involving eIF-2 a-subunit phosphorylation is widely used in animal cells to regulate protein synthesis under various physiological conditions, which include nutritional deprivation (3, 4) , heat shock (4-6), and viral infection (7) (8) (9) (10) (11) (12) (13) (14) .
We have observed that a 67-kDa polypeptide, p67, which remains associated with reticulocyte eIF-2 through several steps of purification, protects the eIF-2 a subunit from eIF-2 kinase-catalyzed phosphorylation, thus promoting protein synthesis in the presence of activated eIF-2 kinases (15). p67 is a glycoprotein and contains multiple 0-linked GlcNAc residues (16) . There are indications that the glycosyl residues on p67 may be necessary to protect the eIF-2 a subunit from eIF-2 kinase-catalyzed phosphorylation. Based on our results, we postulated that protein synthesis in animal cells may be regulated by eIF-2 kinases and by the availability of p67. eIF-2 kinases phosphorylate the eIF-2 a subunit and thus inhibit protein synthesis, and the increased availability of p67 renders the eIF-2 a subunit resistant to eIF-2 kinasecatalyzed phosphorylation, which promotes protein synthesis in the presence of eIF-2 kinases. Two reports from our laboratory are in agreement with this hypothesis (17, 18) .
In the present study, we have examined the roles of p67 and the eIF-2 kinases in regulation of protein synthesis using several animal cell lysates and also an animal cell line (KRC-7) in culture under various growth conditions. We provide evidence that p67 and one or more eIF-2 kinases are present in active forms in all animal cells under normal growth conditions. However, eIF-2 kinases cannot phosphorylate the eIF-2 a subunit because of the presence of p67. Under certain physiological conditions, such as during heme deficiency in reticulocyte lysates and also in serum-starved animal cells in culture, p67 is degraded and thus eIF-2 kinase(s) are able to phosphorylate the eIF-2 a subunit and inhibit protein synthesis. p67 is both inducible and degradable. Also, p67 levels in the cells correlate directly with the protein synthesis activity of the cells, suggesting that p67 plays a critical role in regulation of protein synthesis.
MATERIALS AND METHODS
Most of the materials used in this study were as described (15) (16) (17) . The cloned cell line KRC-7 derived from Reuber H35 rat hepatoma cells was kindly provided by John Koontz (University of Tennessee, Knoxville). A sample of dsI prepared according to Kudlicki et al. (19) was generously Proc. Natl. Acad. Sci. USA 89 (1992) donated by Gisela Kramer (Clayton Foundation, Biochemistry Institute, Austin, TX). A 10,000 x g cell supernatant from rat liver and from rat brain was prepared as described by Pain et al. (20) .
Preparation of Antibodies. Polyclonal antibodies against eIF-2 a or /3 subunits or against p67 were prepared using a modification of the procedure described (15, 16) . The isolated polypeptides were injected into mice. When the antibody titer in the serum was >1:1000, the mouse was injected with TG-180 sarcoma cells (obtained from American Type Culture Collection) for generation of ascites fluid. Antibodies from the ascites fluid were purified on DEAE-Affi-Gel Blue, according to the procedure supplied by the manufacturer (Bio-Rad), and were characterized by NaDodSO4/PAGE followed by immunoblot analysis. dsI was purified from interferon-p-induced HeLa cells by the procedure of Ray et al. (21) and was injected into rabbit. Immune serum from the rabbit was purified on DEAE-Affi-Gel Blue and characterized as above. The monoclonal antibodies against p67 were prepared as described (16) . As reported these monoclonal antibodies specifically recognize the GlcNAc moieties on p67 (16 
RESULTS
Assays for eIF-2 Kinase and p67 Activities. To assay both eIF-2 kinase(s) and p67 activities in a mixture, we developed an experimental procedure that measures eIF-2 a-subunit phosphorylation in the mixture before and after inhibition of p activity by preincubation with either p67 antibodies or wheat germ agglutinin (WGA). As reported (16) , WGA binds to the glycosyl residues on p67 and interferes with the p67 activity to protect the eIF-2 a subunit from eIF-2 kinasecatalyzed phosphorylation.
The results of this assay are shown in Fig. 1 . As before, HRI efficiently phosphorylated the three-subunit eIF-2 (lane 1) and addition of p67 protected the eIF-2 a subunit from phosphorylation (lane 2). However, the ability ofp67 to protect the eIF-2 a subunit was almost completely inhibited by preincubation of the mixture of eIF-2 and p67 with either p67 antibodies (lane 3) or WGA (lane 6). Under similar conditions, preincubation of the mixture of eIF-2 and p67 with either eIF-2 a-subunit or p-subunit antibodies had no significant effect (lanes 4 and 5). None of the antibodies (p67 or eIF-2 a or P subunits), when added alone in the absence of p67, inhibited HRI-catalyzed phosphorylation of the eIF-2 a subunit (data not shown). We also analyzed various antibody-treated incubation mixtures for possible degradation of p67 by a standard immunoblot Assay for eIF-2 kinases and p67 activities. Reaction conditions for HRI-catalyzed phosphorylation of eIF-2 a subunit were as described (15) . A 25-,ul reaction mixture contained 20 mM Tris-HCl (pH 7.8), 100 mM KCI, 10 ,g of bovine serum albumin, 2 mM dithiothreitol, 3 ug of eIF-2 (fraction V), 1.6 ,g of p67, and where indicated 10 ,g of polyclonal antibodies against p67 or against eIF-2 a or ,B subunits or 10 ,ug of WGA. Reaction mixtures were incubated on ice for 1 hr, then 0.02 ug of HRI and 10 ,uCi [y-32P]ATP were added, and the mixtures were further incubated at 37°C for 10 min. The radioactively labeled eIF-2 a subunit was then analyzed by NaDodSO4/PAGE followed by autoradiography. Lanes: 1, eIF-2 alone; 2, eIF-2 plus p67; 3, eIF-2, p67, plus p67 antibodies; 4, eIF-2, p67, plus eIF-2 a-subunit antibodies; 5, eIF-2, p67, plus eIF-2 ,3-subunit antibodies; 6, eIF-2, p67, plus WGA.
procedure. p67 remained undegraded during incubation (data not shown).
We carried out similar experiments using purified dsI in place of HRI and the results were similar. p67 inhibited dsl-catalyzed phosphorylation of eIF-2 a subunits. Also p67 antibodies and WGA inhibited this p67 activity, but eIF-2 aand p-subunit antibodies had no effect.
Studies Using Animal Cell Lysates. We used the above assay to study eIF-2 kinase(s) and p67 activities in four cell lysates; heme-deficient rabbit reticulocyte lysates, heme-supplemented rabbit reticulocyte lysates, and also cell lysates prepared from rat liver and rat brain (Fig. 2) . In the absence of p67 antibodies, significant eIF-2 a-subunit phosphorylation was observed only with heme-deficient reticulocyte lysate. In contrast, the heme-supplemented reticulocyte lysate and also the lysates from liver and brain showed very little or no phosphorylation. However, when the cell lysates were preincubated with p67 antibodies significant phosphorylation of the eIF-2 a subunit was observed with all of the cell lysates. The extent of phosphorylation, with both heme-deficient and heme-supplemented reticulocyte lysates, was comparable. However, it should be noted that, although significant changes in the phosphorylation pattern in all of the cell lysates con-
Analysis of eIF-2 kinases and p67 activities in various cell lysates. Heme-deficient and heme-supplemented reticulocyte lysates and also cell lysates from rat brain and rat liver were used. Hemedeficient and heme-supplemented reticulocyte lysates prepared as described (15) were preincubated at 37°C for 10 min before use.
Approximately 20 /J of reticulocyte lysate or 120 ,g of protein in brain or liver extract was used. eIF-2 a-subunit phosphorylation by endogenous eIF-2 kinase(s) in the presence or absence of p67 antibodies was carried out as described in Fig. 1 
lysates and in rat brain and rat liver lysates showed a similar change in phosphorylation pattern. The significance of this observation will be discussed later.
These results, however, show that both eIF-2 kinase(s) and p67 are present in active forms in all of the cell lysates and p67 inhibits eIF-2 a-subunit phosphorylation by active eIF-2 kinases. Removal of p67 by p67 antibodies facilitated eIF-2 kinase-catalyzed phosphoiylation of the eIF-2 a subunit.
The results presented in Fig. 3 show that p67 is indeed present in heme-supplemented reticulocyte lysate; and this polypeptide is partially deglycosylated in heme-deficient reticulocyte lysate. For these experiments the lysates were preincubated with p67 monoclonal (Fig. 3A) or polyclonal (Fig.  3B) antibodies and the antigen-antibody complexes were precipitated with protein A-agarose (23) . The precipitates were then assayed on an immunoblot using p67 polyclonal antibodies. p67 is present in heme-supplemented reticulocyte lysate (Fig. 3 A and B, lanes 2) and also in heme-deficient reticulocyte lysate (Fig. 3 A and B, lanes 1) . However, the level of this polypeptide in heme-deficient reticulocyte lysate was significantly lower. In experiments described in Fig. 3A, p67 present in the lysates was immunoprecipitated using p67 monoclonal antibodies, which reacted only with glycosylated p67. The p67 level in heme-deficient lysate (lane 1) was <20% of that present in heme-supplemented lysate (lane 2), indicating extensive deglycosylation of p67 in heme-deficient lysate.
These results thus provide evidence that p67 is present in both heme-supplemented and heme-deficient reticulocyte lysates. In heme-deficient Iysate, p67 is partially deglycosylated. This allows eIF-2 kinases to phosphorylate eIF-2 and thus inhibit protein synthesis. Using a similar immunoblot experiment, we also observed that p67 is present in glycosy- A   2   67 kDA---B   2 67kDA-._, a__ lated form in both rat liver and rat brain extracts (data not shown). Studies Using a Tumor Hepatoma Cell Line (KRC-7). We used a tumor hepatoma cell line (KRC-7) and analyzed the roles of p67 and eIF-2 kinase(s) in regulating protein synthesis under various growth conditions. We grew the cells to confluency, then added serum-depleted medium for 3-4 days, and stimulated the serum-starved cells with a mitogen, PMA. We measured the protein synthesis rate, the levels of various polypeptides, and also activation states of eIF-2 kinase(s) at various times during confluency, after serum starvation, and after PMA addition. Protein synthesis rate was measured by incorporation of [35S]methionine into cellular proteins as described (17) . The protein synthesis rate was maximum in confluent cells and was reduced to 30% of the maximum level after 100 hr of serum starvation. Upon PMA addition the serum-starved cells regained 70% of the original protein synthesis activity of the confluent cells within 4 hr.
Levels of Various Polypeptides. Immunoblot analysis was used to measure levels of various polypeptides (p67, dsl, and eIF-2 83 and a subunits) at various times, after serum starvation and after PMA addition (Fig. 4) . p67 levels were measured using both monoclonal and polyclonal antibodies.
dsI and eIF-2,8-and a-subunit levels were measured using polyclonal antibodies. As shown in Fig. 4 , levels of eIF-2 , and a subunits and, more importantly, the level of dsI remained essentially unchanged in confluent (-72 hr), serum-starved, and PMAstimulated cells. On the other hand, p67 levels changed dramatically; p67 was prominent in confluent cells, disappeared rapidly after serum starvation, and became prominent after PMA addition. A significant observation is that p67 level decreased faster after serum depletion and appeared more slowly after PMA addition when measured using monoclonal antibodies than when measured using polyclonal antibodies. These results, in agreement with our observation with hemedeficient reticulocyte lysates (Fig. 3) , suggest that the first step after serum depletion may be deglycosylation of p67 and that deglycosylated p67 is subsequently degraded.
eIF-2 Kinase Activity. The results presented in Fig. 4 were incubated at 4°C overnight and antigen-antibody complexes were precipitated by adding 30 ,ul of protein A-agarose (GIBCO) followed by gentle tapping of the suspension for 1 hr at room temperature. The precipitates were then washed three times with 1 x PBS containing 0.05% Nonidet P-40. The polypeptides in the precipitates were then separated by NaDodSO4/PAGE on 15% gels and subsequently transferred electrophoretically to a nitrocellulose sheet. Lanes were excised from the blot and incubated with p67 antibodies as described by Bio-Rad (Bio-Rad immunoblot assay kit). The antigen-antibody complexes were then detected using goat anti-mouse IgG conjugated to horseradish peroxidase (Bio-Rad analyzed on an immunoblot using p67 monoclonal antibodies (row a), p67 polyclonal antibodies (row b), dsl polyclonal antibodies (row c), eIF-2 /-subunit polyclonal antibodies (row d), and eIF-2 a-subunit polyclonal antibodies (row e). The immunoblot procedure for detection of p67 and eIF-2 a and eIF-2 / subunits was the same as described in Fig. 3 . The immunoblot procedure for detection of dsl was the same except that goat anti-rabbit IgG conjugated to horseradish peroxidase was used to detect dsl rabbit antibodies.
Biochemistry: Ray et A Proc. Natl. Acad. Sci. USA 89 (1992) activities by analyzing eIF-2 a-subunit phosphorylation of endogenous eIF-2 using cell extracts at various times after the assay as described in Fig. 1 . eIF-2 a-subunit phosphorylation was low with extracts from confluent and PMAinduced cells but was significantly increased when a similar extract from quiescent cell was used (Fig. SA) . However, as described in Fig. 1 , when the same cell extracts were first preincubated with p67 polyclonal antibodies to remove endogenous p67 (Fig. SB) or with WGA to inhibit the eIF-2-p67 interaction (Fig. 5C) , the extent of eIF-2 a-subunit phosphorylation using all the cell extracts was significantly increased to approximately the same level.
DISCUSSION
Data presented in this report provide evidence that all animal cells contain one or more eIF-2 kinases in the active form and the activities of these eIF-2 kinases may or may not be evident, depending on the variable presence of p67. p67 protects the eIF-2 a subunit from eIF-2 kinase-catalyzed phosphorylation and thus promotes protein synthesis in the presence of active eIF-2 kinase(s).
In separate experiments we observed that p67 specifically protects the eIF-2 a subunit from both HRI-and dsIcatalyzed phosphorylation but does not inhibit dsI-catalyzed phosphorylation of histones or casein kinase catalyzed phosphorylation of the eIF-2 8 subunit (data not shown). However, the results presented in Fig. 2 indicate that p67 also inhibits phosphorylation of one or more additional proteins (30 and 110 kDa) present in reticulocyte lysates and also in rat brain and rat liver lysates. It may be that under in vitro conditions, the glycosyl residues ofp67 may bind to these additional proteins and thus inhibit their phosphorylation. On the other hand, the possibility that p67 may inhibit phosphorylation of a select group of closely related proteins cannot be ruled out. However, abundant evidence reported previously and also presented in this paper suggests that a major function of p67 is to protect the eIF-2 a subunit from eIF-2 kinasecatalyzed phosphorylation and thus to promote protein synthesis in the presence of active eIF-2 kinases. ,ug of protein in lysates from confluent (lanes -72 serum-starved (lanes -64 hr through 0 hr), and PMA-induced 4 hr) KRC-7 cells was used and phosphorylation eIF-2 a subunit by endogenous eIF-2 kinases described in Fig. 1. ( (Fig. 4) DA-543 protein synthesis activity. Thus, there is a clear correlation between the p67 level and the protein synthesis activity of the cells, indicating a direct involvement of p67 in protein synthesis. Furthermore, a comparison of the p67 levels studied using monoclonal (Fig. 4, row a) and polyclonal (Fig. 4, row  b) antibodies reveals (in agreement with our previous observation with the heme-deficient reticulocyte lysates, Fig. 3 ) that the initial event in p67 degradation involves deglycosylation of p67 and deglycosylated p67 is unstable and is subsequently degraded. These results, therefore, establish the following facts. (i) p67 is necessary to protect the eIF-2 a subunit from eIF-2 kinase-catalyzed phosphorylation and thus to promote protein synthesis in the presence of active eIF-2 kinase(s). (ii) At least one eIF-2 kinase is present in all of the cells in active form under various growth conditions. (iii) p67 is degraded rapidly in serum-depleted cells thus allowing eIF-2 kinase(s) to phosphorylate eIF-2 and inhibit protein synthesis. (iv) The initial event of p7 degradation involves deglycosylation of the p67 polypeptide.
An important aspect of p67 regulation is that this is the only polypeptide presently studied that is both easily degradable and inducible. The levels of this polypeptide correlate directly to the protein synthesis activities ofthe cells. As evident in this study, the initial event for degradation involves deglycosylation of p67. The deglycosylated p67 is unstable and subsequently degraded. Again, addition ofa mitogen, such as PMA, induces increased appearance ofp67, presumably by transcription activation of the p67 gene. Thus, p67 level in the cell is regulated both transcriptionally and posttranscriptionally. This factor is essential for protein synthesis and thus plays a critical role in protein synthesis regulation.
